NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology

Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology

Neuro-Bio was featured in a SelectScience webinar, “How Synthetic Binders Are Transforming Diagnostics and Molecular Biology.” The webinar explored how synthetic binders are providing effective alternatives where traditional antibodies can fall short. Baroness Susan...
Baroness Greenfield’s Presentation “Societal Challenges to live longer and better” at WeMind Forum in Barcelona – November 2024!

Baroness Greenfield’s Presentation “Societal Challenges to live longer and better” at WeMind Forum in Barcelona – November 2024!

In this fascinating Presentation, Baroness Greenfield delved into how we cope with the challenges of living longer and better in our lives, and why each and every one of us is unique. To watch the full Presentation, click here...

LATEST NEWS

  • Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
  • New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
  • Neuro-Bio’s first paper of 2026 has been published!
  • Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures

TOPICS

  • Latest News
  • Media
  • Publications

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025